Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name GSK4381562
Trade Name
Synonyms GSK-4381562|GSK 4381562|SRF813|SRF-813|SRF 813
Drug Descriptions

GSK4381562 (SRF813) is a monoclonal antibody targeting CD112R (PVRIG), which potentially increases NK cell activation and inhibits tumor growth (Cancer Res 2020;80(16 Suppl):Abstract nr 4548).

CAS Registry Number NA
NCIT ID C187105


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Dostarlimab-gxly + EOS-448 + GSK4381562 Dostarlimab-gxly EOS-448 GSK4381562 0 1
Dostarlimab-gxly + GSK4381562 Dostarlimab-gxly GSK4381562 0 1
GSK4381562 GSK4381562 0 1

Additional content available in CKB BOOST